Keywords: ADCC; antibody dependent cellular cytotoxicity; AUC; area under the concentration-time curve; CL; clearance; mAbs; monoclonal antibodies; M-M; Michaelis-Menten; PBS; phosphate-buffered saline; PK; pharmacokinetic; TMB; tetramethylbenzidine; TMDD; ta
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Minimal physiologically-based pharmacokinetic model to investigate the effect of pH dependent FcRn affinity and the endothelial endocytosis on the pharmacokinetics of anti-VEGF humanized IgG1 antibody in cynomolgus monkey
Keywords: AIC; Akaike Information Criterion; ATA; anti-therapeutic antibody; AUC; area under the curve; CLe; antibody clearance in endothelial space; CDP; Complex Dedrick Plot; CV; coefficient of variations; FR; recycling fraction of IgG; F1; modulation factor of m
PK/PD analysis of a novel pH-dependent antigen-binding antibody using a dynamic antibody-antigen binding model
Keywords: Monoclonal antibody; pH-dependent antigen-binding; FcRn; TMDD; PK/PD;
Pharmacokinetics of an anti-TFPI monoclonal antibody (concizumab) blocking the TFPI interaction with the active site of FXa in Cynomolgus monkeys after iv and sc administration
Keywords: TFPI; Nonmem; Haemophilia; TMDD; Concizumab; mAb 2021
Printing ink and paper recycling sources of TMDD in wastewater and rivers
Keywords: TMDD; Paper recycling factories; Printing inks; WWTPs;
Screening of dioxin-like compounds by complementary evaluation strategy utilising ELISA, micro-EROD, and HRGC-HRMS in soil and sediments from Montevideo, Uruguay
Keywords: PCDD; polychlorinated dibenzo-p-dioxins; PCDF; polychlorinated dibenzofurans; PCB; polychlorinated biphenyls; PAH; polycyclic aromatic hydrocarbons; HRGC/HRMS; high resolution gas chromatography and high resolution mass spectrometry; DMEM; Dulbecco's Mi
Monoclonal Antibodies for Therapeutic Use: Specific Characteristics of Clinical Development, Evaluation by the Agencies, and Long-term Monitoring of Safety
Keywords: monoclonal antibodies; clinical trials, phase I; clinical trials, phase II; clinical trials, phase IV; ADCC; antibody dependent cellular cytotoxicity; (ex-)Afssaps; ex-Agence française de sécurité sanitaire des produits de santé (at present french Nat